Category: Pharmaceutical

The global autologous fat grafting market is projected to expand at a healthy CAGR of close to 10% from 2021 to 2031. By application, breast augmentation holds the highest market share of over 45%.

Autologous fat grafting systems are used for precise and faster fat processing, which eliminates the use of laborious manual procedures. This makes the overall fat grafting process effective and more affordable. Autologous fat transfer systems and accessories find major application in minimal and non-invasive cosmetic procedures.

Fact.MR, in its revised research report, tracks the global sales of autologous fat grafting in 20+ high-growth markets, with North America and Europe the largest regional markets.

Medical Membranes Market size is done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease epidemiology for any key indications , number of procedures and install base analysis for any equipment to obtain precise market estimations  for the base year as well as in historic data analysis. Bottom-up approach is always used to obtain Medical Membranes insightful data for the specific country/regions.

The country specific data is again analyzed to derive data at a global level. Specific factors/parameters are considered related to the individual Medical Membranes market and quantified with insightful rationale.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-https://www.factmr.com/connectus/sample?flag=S&rep_id=6661

The Market survey of Medical Membranes offers a comprehensive analysis of diverse features, including production capacities analysis of Medical Membranes, demand, product developments, revenue generation, and Size of Medical Membranes Market across the globe.

Key Market Segments Covered in Medical Membranes Industry Research

• By Material

  • Polysulfone PSU & Polyethersulfone PESU
  • Hydrophilic polyvinylidene fluoride PVDF
  • Polytetrafluoroethylene PTFE
  • Polypropylene PP
  • Polyethylene
  • Modified Acrylics

• By Process Technology

  • Ultrafiltration
  • Microfiltration
  • Nanofiltration
  • Reverse Osmosis
  • Dialysis
  • Gas Filtration

• By Application

  • Medical Membranes Used in Pharmaceutical Filtration
  • Medical Membranes Used in Haemodialysis
  • Medical Membranes Used in Drug Delivery
  • Medical Membranes Used in IV Infusion & Sterile Filtration
  • Medical Membranes Used in Bio-artificial Processes

Key Parameters analyzed while estimating the Medical Membranes market include:

• To analyze Drugs/ Therapeutic Area in Medical Membranes :

Overall Population by age group/Prevalence or Incidence of any disease/Treatment Seeking Rate/Dosage pattern/Average duration of treatment/Overall treatment cost and Reimbursement are considered.

• To analyze Consumables of Medical Membranes:

Overall Population/Prevalence or Incidence of disease/treatment seeking rate/ average duration of the treatment/average number of devices used per patient / average number of procedure per device/ average selling price per device/reimbursement are considered.

• To analyze Medical Membranes Equipment:

Number of Healthcare facilities (Hospitals/Ambulatory Surgical Centers/Clinics etc.)

Average number of devices installed per facilities/ lifespan of the devices/replacement rate of the equipment/new sales of the equipment per year/average selling price per equipment are considered.

Need More information about Report Methodology? Click here:-https://www.factmr.com/connectus/sample?flag=RM&rep_id=6661

Competitive Landscape

Key players are adopting several organic and inorganic growth strategies to strengthen their foothold in the market. Many companies expanded their production facilities and acquired other businesses to strengthen their position in the global market.

Some of the key developments are:

• In 2017, 3M Company (US) made an investment of US$ 40 Mn to expand its dialysis membrane production facility. This expansion will help company to increase its customer base and strengthen its foothold in the market.
• In August 2017, Merck Millipore (US) acquired Natrix Separation (Canada), which is hydrogel membrane provider. This acquisition will help Merck Millipore (US) in increasing its product portfolio, customer base, and strengthen its foothold in North America.
• In December 2017, Asahi Kasei Medical announced the construction of a new plant for the spinning of cellulose hollow fiber membranes for its virus removal filters called Planova.

In September 2016, Sartorius launched a PES membrane, which is integrated into the sterile Sartocon benchtop and production scale filtration assemblies.

To get all-in insights on the regional landscape of the Medical Membranes Market, buy now:-https://www.factmr.com/checkout/6661

After reading the Market insights of Medical Membranes Report, readers can:

• Understand the drivers, restraints, opportunities and trends affecting the Sales of market.
• Analyze key regions holding significant share of total Medical Membranes market revenue.
• Study the growth outlook of Medical Membranes market scenario, including production, consumption, history and forecast.
• Learn consumption pattern and impact of each end use & supply side analysis of Medical Membranes market.
• Investigate the recent R&D projects performed by each market player & competitive analysis of Medical Membranes Market Players.

How Fact.MR Assists in Making Strategic Moves For Medical Membranes Market Manufacturer?

• The data provided in the Medical Membranes market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.
• The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.

For More Insights from Fact.MR :-MarketNgage – https://www.youtube.com/watch?v=eJwgHnzdRSs

About Fact.MR:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

 Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

A recent study by Fact.MR on the wireless portable medical devices market offers a 10-year forecast for 2021 to 2031. The study analyses crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering wireless portable medical devices.

The Market survey of Wireless Portable Medical Devices offers a comprehensive analysis of diverse features, including production capacities analysis of Wireless Portable Medical Devices, demand, product developments, revenue generation, and Size of Wireless Portable Medical Devices Market across the globe.

The Demand analysis of Wireless Portable Medical Devices Market offers a comprehensive analysis of diverse features, demand, product developments, revenue generation, and sales of Wireless Portable Medical Devices Market across the globe.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):https://www.factmr.com/connectus/sample?flag=S&rep_id=6588

A comprehensive estimate of the Wireless Portable Medical Devices market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the Sales of Wireless Portable Medical Devices during the forecast period. Price point comparison by region with the global average price is also considered in the study.

Key stakeholders in Market including industry players, policymakers, and investors in various countries have been continuously realigning their strategies and approaches to implement them in order to tap into new opportunities.

Need More information about Report Methodology? Click here:https://www.factmr.com/connectus/sample?flag=RM&rep_id=6588

Some Notable Offerings by Fact.MR Report on Wireless Portable Medical Devices market:

• We will provide you an analysis of the extent to which this Wireless Portable Medical Devices market research report acquires commercial characteristics along with examples or instances of information that helps you to understand it better.
• We will also help to identify customary/ standard terms and conditions, as offers, worthiness, warranty, and others.
• Also, this report will help you to identify any trends to forecast growth rates.
• The analyzed report will forecast the general tendency for supply and demand.

Some of the Wireless Portable Medical Devices Market insights and estimations that make this study unique in approach and effective in guiding stakeholders in understanding the growth dynamics. The study provides:

• Details regarding latest innovations and development in Wireless Portable Medical Devices and how it is gaining customer traction during the forecast period.
• Analysis about the customer demand of the products and how it is likely to evolve in coming years.
• Latest regulations enforced by government bodies and local agencies and their impact on Demand of Wireless Portable Medical Devices Market .
• Insights about adoption of new technologies and its influence on the Wireless Portable Medical Devices market Size.
• Overview of the impact of COVID-19 on Wireless Portable Medical Devices Market and economic disruptions caused by the pandemic.
• Evaluates post-pandemic impact on the Sales of Wireless Portable Medical Devices Market during the forecast period.

To get all-in insights on the regional landscape of the Wireless Portable Medical Devices Market, buy now:https://www.factmr.com/checkout/6588

After reading the Market insights of Wireless Portable Medical Devices Report, readers can:

• Understand the drivers, restraints, opportunities and trends affecting the Sales of market.
• Analyze key regions holding significant share of total Wireless Portable Medical Devices market revenue.
• Study the growth outlook of Wireless Portable Medical Devices market scenario, including production, consumption, history and forecast.
• Learn consumption pattern and impact of each end use & supply side analysis of Wireless Portable Medical Devices market.
• Investigate the recent R&D projects performed by each market player & competitive analysis of Wireless Portable Medical Devices Market Players.

How Fact.MR Assists in Making Strategic Moves For Wireless Portable Medical Devices Market Manufacturer?

• The data provided in the Wireless Portable Medical Devices market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.
• The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.

Explore Fact.MR’s Coverage on the Healthcare Domain

Genetic Testing Services Market – The future expansion of genetic testing services is heavily reliant on the advancement of information technology. Throughout the projected period, North America is expected to dominate the worldwide genetic testing services market. Increased demand for genetic testing to determine ancestry, as well as an increase in demand for in-vitro fertilization (IVF) and pre-implantation testing, are some of the primary reasons boosting market share. According to projections, the North American genetic testing market will account for over two-fifths of the total.

Rheumatoid Arthritis Stem Cell Therapy Market – Over the forecast period, the global market for rheumatoid arthritis treatments is expected to rise moderately. Over the projected period, the allogeneic mesenchymal stem cell segment is expected to lead the global rheumatoid arthritis stem cell therapy market. As the most accessible channel, hospitals are likely to account for a sizable portion of the global rheumatoid arthritis stem cell therapy market.

Serological Transplant Diagnostics Market – Serological transplant diagnosis, which is a critical component of successful and efficient organ transplantation, has grown rapidly in recent years. Growth in important distribution channels, such as hospitals and organ transplantation centres, to name a few, has boosted demand during the last five years, from 2016 to 2020, attracting more stakeholders to the business. Serological transplant diagnostic equipment sales are being fueled by an increase in incidence of serious lung, liver, and kidney disorders, as well as medical and diagnostic developments.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

The medical radiation detection, monitoring and safety market study by Fact.MR offers insights into key growth drivers and restraints impacting the growth trajectory through 2031. The survey offers medical radiation detection, monitoring and safety demand outlook and studies opportunities existing in key segments, including radiation and monitoring products and detectors. It also highlights key strategies adopted by market players to increase product sales.

Fact.MR – A Market Research and Competitive Intelligence Provider: In 2020, the global market for medical radiation detection, monitoring, and safety was estimated to be worth US$ 880 million. According to Fact.MR, the market is expected to grow at a CAGR of 6% over the forecast period, reaching a valuation of US$ 1.5 billion by 2031.

The medical radiation detection, monitoring and safety market is being driven by rising cancer prevalence, increased use of nuclear medicine and radiation treatment, growth of diagnostic imaging centers, and increased safety awareness among people working in radiation-prone areas.

Cancer is the second-leading cause of mortality globally, according to the World Health Organization (WHO), with an estimated 9.6 million deaths in 2018. Various measures and therapies are being implemented to combat the increased occurrence of illnesses.

Want A Detailed Understanding of Market Functioning? Request for a Sample Here

https://www.factmr.com/connectus/sample?flag=S&rep_id=6505

Around the world, several radiation therapies are used to treat cancer patients. Over 40 million nuclear medical treatments are performed each year, according to the World Nuclear Association.

However, both health professionals and patients are at danger of being exposed to hazardous radiations. A significant array of medical radiation detection, monitoring, and safety products are used to prevent this.

Because of the increased usage of ionizing radiation during the last decade, patients have been exposed to more radiation. As a result, several of the market’s leading companies are concentrating on producing efficient and cost-effective products to mitigate the effects of radiation exposure.

The market has seen the introduction of new gear and devices as a result of recent technological breakthroughs. In many hospitals and diagnostic institutes, X-ray diffraction equipment and X-ray machines are being installed. As a result, there is a growing demand for advanced medical radiation safety equipment.

The number of people with health insurance is increasing, which has an indirect impact on the market for medical radiation detection, monitoring, and safety.

With a market share of roughly 50% in 2020, gas-filled detectors will lead the global market. Their increasing use in Geiger-Muller counters, ionization chambers, and proportional chambers can be linked to this.

North America will continue to dominate the global medical radiation detection, monitoring, and safety market with a share of over 40% due to recent technical breakthroughs, advanced healthcare infrastructure, and the presence of prominent industry players.

“Launch of radiation safety programs and development of efficient and cost-effective products will drive the medical radiation detection, monitoring and safety market during the forecast period”, says the Fact.MR analyst.

Key Takeaways

• With a market value of over $300 million, the United States dominates the medical radiation detection, monitoring, and safety industry.

• With increasing incidence in cancer and improved healthcare infrastructure, the market in China is set to reach a valuation of US$ 105 Mn by 2031 end.
• During the projected period, Canada is expected to provide lucrative growth possibilities for medical radiation detection, monitoring, and safety product makers.
• During the projected period, Asia Pacific is expected to provide lucrative growth possibilities for medical radiation detection, monitoring, and safety product makers. This is due to an increase in the number of hospitals and diagnostic centers, as well as the increasing use of radiation treatment to treat severe diseases like cancer.
• The top five players in the medical radiation detection, monitoring, and safety equipment market control over 40% of the global market.
• Owing to the adoption of gas-filled detectors across wide applications, the segment leads the medical radiation detection, monitoring and safety market with a market share of around 50%.

Key Drivers

• The medical radiation detection, monitoring, and safety market is being driven by the rising prevalence of cancer.
• The need for medical radiation detection, monitoring, and safety equipment is increasing as people working in radiation-prone workplaces become more concerned about their safety.
• The expansion of the total market will be aided by the availability of insurance coverage and advantageous reimbursement rules.
• During the projection period, rapid expansion of diagnostic centers all over the world is expected to generate rapid growth.

Key Restraints

• Shortage of skilled professionals is hindering the market growth.
• Risks associated with exposure of harmful radiation hampers the market growth.
• The high expense of cancer treatment has a detrimental impact on the market.

To gain in-depth insights on Medical Radiation Detection, Monitoring and Safety Market, request methodology at

https://www.factmr.com/connectus/sample?flag=RM&rep_id=6505

Competitive Landscape

Key Companies operating in the self-care medical devices market are focusing on expanding their customer base across several end-use industries. They are adopting various organic and inorganic growth strategies such as mergers and acquisitions, advanced product development and collaborations to gain a competitive edge in the market.

• In January 2021, Mirion Technologies, Inc., a global provider of innovative radiation detection and measurement solutions acquired Sun Nuclear Corporation, the global leader in radiation oncology quality assurance, delivering patient safety solutions for diagnostic imaging and radiation therapy centers around the world.
• In 2019, Radition detection specialist Arktis Radiations Detectors developed a new flat panel gamma (FPG) detector which will improve the capability for detecting radioactive sources in a variety of applications
• Similarly in May 2019 Kromek launched a high-speed spectroscopic radiation detector (SPRD) named D3S PRD that puts a very powerful and sensitive radiation detector into the hands of first-line users.

Some of the leading players operating in the medical radiation detection, monitoring and safety market profiled by Fact.MR are:

• Amray Group
• Arktis Radiation Detectors Ltd
• Mirion Technologies, Inc.
• Sun Nuclear Corporation
• Thermo Fisher Scientific, Inc.
• Fortive Corporation
• Bertin Instruments
• Polimaster, Inc.
• Biodex Medical Systems, Inc.
• PTW Freiburg GmBH
• Ludlum Measurements, Inc.
• Bar-Ray Products Inc.
• Arrow-Tech Inc.
• Infab Corporation

More Valuable Insights on the Global Medical Radiation Detection, Monitoring and Safety Sales Outlook

Fact.MR provides an unbiased analysis of medical radiation detection, monitoring and safety market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the global demand for Medical Radiation Detection, Monitoring and Safety products with a detailed segmentation on the basis of:

Radiation and Monitoring Products

• Personal Dosimeters
• Area Process Monitors
• Environmental Radiation Monitors
• Surface Contamination Monitors
• Radioactive Material Monitors

Detector

• Gas-filled Detectors
• Scintillators
• Solid State Detectors

Safety

• Full Body Protection
• Face Protection
• Hand Protection

End User

• Medical Radiation Detection, Monitoring and Safety Systems for Hospitals
• Medical Radiation Detection, Monitoring and Safety Systems for Clinics
• Medical Radiation Detection, Monitoring and Safety Systems for Ambulatory Surgical Centers
• Medical Radiation Detection, Monitoring and Safety Systems for Non-Hospitals

Key Questions Covered in the Medical Radiation Detection, Monitoring and Safety Sales Outlook Report

• The report offers insight into medical radiation detection, monitoring and safety demand outlook for 2021-2031
• The market study also highlights projected sales growth for medical radiation detection, monitoring and safety market between 2021 and 2031
• Medical radiation detection, monitoring and safety market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
• Medical radiation detection, monitoring and safety market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others

Explore Fact.MR’s Coverage on the Healthcare Domain –

MRI-guided Radiation Therapy Systems Market Scope – The emergence of new technologies in the healthcare and medical equipment industries has supported the MRI-guided radiation therapy systems market. MRI-guided radiation therapy systems are in high demand due to the growing use of irradiation in cancer treatment.

Image Guided Radiotherapy Market Insights – The global imaging guided radiotherapy market is growing at an exponential rate, owing to the increasing prevalence of malignant growth and increased interest in cutting-edge therapies, which is the primary driver of the imaging guided radiotherapy market.

Radiotherapy Devices Market Forecast – The global cancer incidence rate is predicted to skyrocket in the next years, owing to the introduction of new consequences resulting from exposure to harmful elements. The need for radiotherapy devices will continue to rise as radiotherapy becomes more widely used in cancer treatment.

Image Guided Surgery Devices Market Trends – Growing demand for minimally invasive operations as a result of improved clinical results, technical advancements in imaging, and collaboration between the public and private sectors in the past drove demand for image guided surgery.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology to even the most niche categories. 80% of Fortune 1000’s trust us in critical decision making.

MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
You can access all our healthcare research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.

Contact:

Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com

According to Fact.MR, the sales of plasma fractionation is expected to register a CAGR of more than 7% along with the market size being valued at US$ 38 Bn at the end of the 2021-2031 forecast period. Rising prevalence of infectious and chronic diseases is majorly spurring expansion of the market.

As per historical trends, between 2016 and 2020, demand for plasma fractionation surged at a CAGR of 5%, closing in at a valuation of US$ 19 Bn. The impact of COVID-19 has been tremendously huge on the plasma fractionation market. Increase in respiratory problems and blood disorders has led to patients opting for plasma fractionation. Technological advancements in the plasma fractionation sector has further propelled the growth of plasma fractionation.

Prominent manufacturers are expected to capitalize on the ever-growing prospects for treating neurological disorders. Statistics suggest that these disorders have affected 450 million globally. Thus, the neurology segment for plasma fractionation is expected to witness robust growth by registering a CAGR of 7.2%

For detailed insights on enhancing your product footprint, request a sample here-  https://www.factmr.com/connectus/sample?flag=S&rep_id=4806

A detailed assessment of the plasma fractionation market value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the plasma fractionation market along with their product portfolio enhances the reliability of this comprehensive research study.

“Burgeoning technological innovations, combined with widespread usage of immunoglobulins for treating various neurological and autoimmune diseases shall broaden growth prospects. A positive growth trajectory is predicted for the plasma fractionation market during the forecast period,” infers a Fact.MR analyst.

Prominent manufacturers with established market presence in global Plasma fractionation market are

• GRIFOLS
• Sanquin
• CSL Behring Limited
• Shire Plc.
• Biotest AG
• Baxter International

COVID-19 Analysis on the Global Plasma Fractionation Market

A recent market research report on the Plasma Fractionation market published by Fact.MR is an in-depth assessment of the current landscape of the market. Further, the report elaborates on the impact of the COVID-19 on the Plasma Fractionation market and provides a thorough understanding of the growth potential of each market segment over the forecast period (2020 to 2026).

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4806

Plasma Fractionation Market: Report Summary

The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in the plasma fractionation market across the globe.

A comprehensive estimate on the plasma fractionation market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of plasma fractionation market during the forecast period.

 Plasma Fractionation Market Segmentation

Fact.MR has studied the plasma fractionation market with detailed segmentation on the basis of product, application, end-user and region.

For comprehensive insights on this market adoption, ask an analyst here- https://www.factmr.com/connectus/sample?flag=AE&rep_id=4806

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

For in-depth competitive analysis, buy now-  https://www.factmr.com/checkout/4806

Plasma Fractionation Market: Analysis on Market Size Evaluation

The plasma fractionation market has been analyzed for each market segment, in terms of value (US$ Mn).

Market estimates at global and regional levels for Plasma fractionation market is available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent plasma fractionation market segments, along with market attractiveness evaluation has been incorporated in the report.

Plasma Fractionation Market: Inspected Assessment on Regional Segments

Key sections have been elaborated in the plasma fractionation report, which have helped deliver projection on the regional markets. These chapters include the regional macros (economic and business environment outlook), which are expected to have a momentous influence on the growth of the plasma fractionation market during the forecast period.

For More Insights:  https://www.prnewswire.com/news-releases/ear-nose-throat-ent-medical-devices-manufacturers-target-applications-in-cataract–glaucoma-treatment-factmr-301262063.html

Country-specific valuation on demand for plasma fractionation has been offered for each regional market, along with the market scope estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value for emerging countries has also been included in the report.

Plasma Fractionation Market: In-Depth Analysis on Competitive Landscape

The report sheds light on the leading manufacturers of plasma fractionation products along with their detailed profiles. Essential and up-to-date data information related to the market performers, who are principally engaged in the production of plasma fractionation products, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, such as product portfolio, key strategies along with an all-inclusive SWOT analysis on each player. Company presence is mapped and presented through the matrix for all the prominent players thus providing the readers with actionable insights, which helps in thoughtfully presenting market status, and predicting the competition level in the plasma fractionation market. Prominent manufacturers with established market presence in global Plasma fractionation market are GRIFOLS, Sanquin, CSL Behring Limited, Shire Plc., Biotest AG, Baxter International, etc.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

This wide array of applications are anticipated to bolster prospects for the global high performance liquid chromatography market during the forecast period (2020-2026). Anticipated CAGR during this period is pegged at 5.4%. High Performance Liquid Chromatography (HPLC) is a highly sophisticated and an expensive technique, used to separate and identify various compounds in liquids and tissues.

Click HERE To Get A SAMPLE (Including Full TOC, Table & Figures) At- https://www.factmr.com/connectus/sample?flag=S&rep_id=4791

HPLC techniques have been widely used in food processing, clinical diagnosis and forensic sciences. The technique is commonly used for drug analysis, separation of molecules and environmental control. The recent COVID-19 pandemic is poised to moderately impact testing volumes due to a number of the key companies’ employees practicing social distancing. Nevertheless, overall growth prospects shall remain positive.

Key Takeaways of Global HPLC Market Study:

• By product type, the instruments segment is poised to be leveraged the maximum in the global HPLC market. This is attributed to the reduction in the usage of detectors and pumps in favor of more accurate and precise instruments. The segment is anticipated to capture more than 2/5^th of the overall market.
• By end-users, pharmaceutical & biotechnology industry and diagnostic laboratories segments shall grow at a CAGR of 5.7% each, burgeoned by increased government initiatives to fund small-scale industries and entry of existing market players and the rising prevalence of chronic diseases.
• The food and beverage industry shall expand rapidly, owing to the increasing demand for nutritious food and better packaging. The segment is poised to expand 1.4x, capturing more than 1/5^th of the global HPLC market.
• By region, Europe is anticipated to capture nearly one-third of the global HPLC market, growing at a CAGR of 4.4%. Increasing investments by key players in the pharmaceutical and biotechnology industry, as well as government intervention in the field of environmental control and food safety is poised to leverage the region’s growth.
• Asia-Pacific shows promising growth prospects. This is attributed to increasing investments by key players in clinical research and development of new drugs to provide innovative treatment options. A CAGR of 5.3% is predicted for the region.

Need More Information About Report Methodology? Click Here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4791

“The global HPLC market is poised to expand on a positive growth trajectory in the future. The wide range of applications of HPLC techniques has prompted key players to invest heavily in strengthening their product portfolios to offer novel solutions. While the COVID-19 pandemic may limit the volumes of testing, the overall growth trend is poised to remain elevated,” interprets a Fact.MR analyst.

Global HPLC Market: Research and Development Initiatives to Define Competition Landscape

The global HPLC market comprises of the following players: Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Waters Corporation, GE Healthcare, Shimadzu Corporation, PerkinElmer Inc., Gilson, Inc., and Phenomax, Inc., to name a few. These companies have invested in strengthening their product portfolio and research and development operations.

Waters Corporation is a leading life sciences company which designs, develops and markets liquid chromatography instruments, such as the Alliance HPLC System which provides advanced solvent delivery capabilities. Similarly, Agilent Technologies specializes in three categories of HPLC systems: Analytical, Application-Specific and Preparative Systems.

Full Access Of This Exclusive Report Is Available At- https://www.factmr.com/checkout/4791/S

COVID-19 Market Insights:

The leading players in the HPLC market consider the well-being of their staff of primary importance. Most players like Agilent Technologies have established business continuity plans (BCPs) to ensure that their production does not fall behind. The BCPs cover the physical infrastructure of the site, supply-chain disruptions and logistics.

The company has a diversified supply chain which helps guarantee surety of supply. While most of the workforce operates from home, there are a few workers who have to work on-site. For them, additional precautionary measures are being taken by leading players such as increased cleaning and disinfection, screening and restricted access for visitors and availability of personal protective equipment.

Looking for more information?

The research study on the global high performance liquid chromatography (HPLC) market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global blood transfusion diagnostics market over 2020-2026. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2026. Market statistics have been presented on the basis of Product Type (Instruments, Consumables and Accessories) and End-user (Pharmaceutical & Biotechnology Industries, Diagnostic Laboratories, Food & Beverage Industry, Academic and Research Institutes and Others) across five major regions

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com

250 page market research report by Fact.MR, leading business and competitive intelligence provider, analyzing how High-flow Nasal Cannula Market Sales will grow.

The latest research report published by Fact.MR on the Survey of High-flow Nasal Cannula Market is intended to offer reliable data on various key factors shaping the growth curve & outlook of High-flow Nasal Cannula market. This report works as a rich source of information for key entities such as policy makers, end-use industries, investors, and opinion leaders.

The Demand analysis of High-flow Nasal Cannula Market offers a comprehensive analysis of diverse features, demand, product developments, revenue generation, and sales of High-flow Nasal Cannula Market across the globe.

High-Flow Nasal Cannula Market Size and Growth

The high-flow nasal cannula market is anticipated to showcase a robust CAGR of 11.8% during the forecast period (2020-2025). Technological advancements by key market players are also anticipated to burgeon the high-flow nasal cannula market. Moreover, clinical trials for evaluating new application areas shall open up new avenues for the market.

According to the Global Burden of Disease Study, 2013, around 300 million people suffered from COPD during that year. This is attributed to growing addiction for smoking, deteriorating air quality and rising pollution across the globe. The prevalence of respiratory disorders will further boost market prospects.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-  https://www.factmr.com/connectus/sample?flag=S&rep_id=4777

A comprehensive estimate of the Demand of High-flow Nasal Cannula market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the Sales of High-flow Nasal Cannula during the forecast period. Price point comparison by region with the global average price is also considered in the Survey study of High-flow Nasal Cannula market.

The analysts have used numerous industry-wide prominent business intelligence tools to consolidate facts, figures, and market data into Sales revenue estimations and projections in the Market Insights of High-flow Nasal Cannula.

Key stakeholders in High-flow Nasal Cannula Market including industry players, policymakers, and investors in various countries have been continuously realigning their strategies and approaches to implement them in order to tap into new opportunities.

The Market survey of High-flow Nasal Cannula offers a comprehensive analysis of diverse features, including production capacities analysis &Insights of High-flow Nasal Cannula Market, demand of High-flow Nasal Cannula market, product developments, revenue generation, and Size of High-flow Nasal Cannula Market across the globe.

Key Highlights from the Insights Report of High-flow Nasal Cannula Market:

• Elaborated scenario of the parent market
• Transformations in the Demand of High-flow Nasal Cannula market dynamics
• Detailed segmentation of the target market.
• Historical, current and forecast of High-flow Nasal Cannula market size based on value and volume
• Latest industry developments and Market trends of High-flow Nasal Cannula
• competitive analysis of High-flow Nasal Cannula Market
• Strategies adopted by the High-flow Nasal Cannula market players and product developments made
• Potential and niche segments, along with their regional analysis
• Unbiased analysis on market size of High-flow Nasal Cannula
• Up-to-date and must-have intelligence for the market players to enhance and sustain their competitiveness

High-flow Nasal Cannula Market Segmentation

Fact.MR has studied the high-flow nasal cannula market with detailed segmentation on the basis of component, application, end-user and key regions.

Component

• Air/Oxygen Blend
• Air Humidifier
• Single Heated Tube
• Nasal Cannula
• Other Consumables

Application

• Acute Respiratory Failure
• Chronic Obstructive Pulmonary Disease (COPD)
• Carbon Monoxide Toxicity
• Bronchiectasis
• Sleep Apnea
• Acute Respiratory Failure
• Other Applications

End-user

• Hospitals
• Long-term Care Centers
• Ambulatory Care Centers
• Tomosynthesis
• Other End-users

Key Regions

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Buy Now for Exclusive Analyst Support :-  https://www.factmr.com/checkout/4777

Some Notable Offerings by Fact.MR Report on High-flow Nasal Cannula market:

• We will provide you an analysis of the extent to which this Outlook of High-flow Nasal Cannula market research report acquires commercial characteristics along with examples or instances of information that helps you to understand it better.
• We will also help to identify customary/ standard terms and conditions, as offers, worthiness, warranty, and others.
• Also, Outlook of High-flow Nasal Cannula market research report will help you to identify any trends to forecast growth rates.
• The analyzed report will forecast the general tendency for supply and demand of High-flow Nasal Cannula market.

Competitive Analysis of High-flow Nasal Cannula Market:

The global high-flow nasal cannula market is fragmented. Out of the existing players, four of them account for three-tenth of the market share. These companies are Fisher & Paykel Healthcare Limited, BD/CareFusion, ResMed Inc., and Telefax incorporated. These players are consistently innovating their product portfolios by virtue of technological advancements to acquire market presence.

Fisher & Paykel is a leading players in the global high-flow nasal cannula market. Its flagship products include F&P 950 Humidifier, Optiflow High-flow System and the AIRVO 2. Other products include OptiFlowTM Nasal High, F&P Brevida Masks and the F&P SimplusTM Full Face Masks.

ResMed, Inc. is another market leader in the respiratory therapy market. It offers a strong product portfolio for the treatment of sleep apnea and non-invasive ventilation. Its flagship products include AirView, myAir and ClimateLine MAX for the treatment and management of sleep apnea and respiratory disorders.

How Fact.MR Assists in Making Strategic Moves For High-flow Nasal Cannula Market Manufacturer?

The data provided in the Survey Report of High-flow Nasal Cannula market offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.

The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.

Some of the High-flow Nasal Cannula Market insights and estimations that make this study unique in approach and effective in guiding stakeholders in understanding the growth dynamics. The study provides: 

• Details regarding latest innovations and development in High-flow Nasal Cannula and how it is gaining customer traction during the forecast period.
• Analysis about the customer demand of the products and how it is likely to evolve in coming years.
• Latest regulations enforced by government bodies and local agencies and their impact on Demand of High-flow Nasal Cannula Market .
• Insights about adoption of new technologies and its influence on the High-flow Nasal Cannula market Size.
• Overview of the impact of COVID-19 on High-flow Nasal Cannula Market and economic disruptions caused by the pandemic.
• Evaluates post-pandemic impact on the Sales of High-flow Nasal Cannula Market during the forecast period.

USP OF REPORT : DON’T PAY UNTIL YOU ARE SATISFIED – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4777

After reading the Market insights of High-flow Nasal Cannula Report, readers can:

• Understand the drivers, restraints, opportunities and trends affecting the Sales of market.
• Analyze key regions holding significant share of total High-flow Nasal Cannula market revenue.
• Study the growth outlook of High-flow Nasal Cannula market scenario, including production, consumption, history and forecast.
• Learn consumption pattern and impact of each end use & supply side analysis of High-flow Nasal Cannula market .
• Investigate the recent R&D projects performed by each market player & competitive analysis of High-flow Nasal Cannula Market Players.

High-Flow Nasal Cannula Regional Insights

North America is anticipated to dominate the high-flow nasal cannula market during the forecast period. Preference for non-invasive ventilation (NIV) and continuous positive airway pressure (CPAP) devices has augmented rapidly in home care settings for patients suffering from respiratory diseases in North America.

This has stimulated key manufacturers to increase production of high-flow nasal cannula devices, thus increasing the market share. The North American high-flow nasal cannula market share is projected to be more than two-fifth.

Asia-Pacific shows impressive growth prospects for the high-flow nasal cannula market during the forecast period. The Asia-Pacific region is anticipated to expand at a CAGR of 13.2%, capturing a market share of almost one-fifth of the total high-flow nasal cannula market.

Increasing population, degraded air quality and growing smoking prevalence have increased the number of respiratory disease cases. This has augmented the market for high-flow nasal cannula market in Asia-Pacific.

Read More Trending Reports of Fact.MR: –  https://www.globenewswire.com/en/news-release/2020/03/27/2007702/0/en/Tricuspid-Valve-Repair-Market-Poised-for-Astounding-Growth-Through-2029-Fact-MR-Projects-Annuloplasty-Rings-to-Remain-Top-Selling.html

Reasons to choose a Fact.MR:

• Exhaustive research regarding the market to offer A to Z information.
• Digital technologies to provide innovative business solutions to clients.
• 24/7 availability of services.
• Interaction with suppliers, vendors, and service providers for a precise market landscape.
• Reports tailored as per the requirements of the clients.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. High-flow Nasal Cannulanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Helicobacter Pylori infections, or H. Pylori, are the most common types of infections affecting the digestive tract. The infection is prevalent among half of the world’s population, who typically reside in unhygienic and poor sanitary conditions. It is the most common reason for dyspepsia, peptic ulcers and gastric adenocarcinoma.

Click HERE To Get A SAMPLE (Including Full TOC, Table & Figures) At- https://www.factmr.com/connectus/sample?flag=S&rep_id=4774

In view of this, the demand for H. Pylori testing has increased, particularly non-invasive molecular techniques such as real-time PCR and Chemiluminescence Immunoassay (CLIA). The Helicobacter Pylori Non-Invasive Testing market is anticipated to register a moderate CAGR of 3.9% during the forecast period (2020-2026).

Key Takeaways of Global H. Pylori Non-Invasive Testing Market Study:

• By test type, the urea breath test segment is anticipated to hold a major chunk of the market, amounting to over two-fifth. High rate of accuracy in detecting the presence of H. Pylori and usefulness in evaluating post-treatment status are poised to leverage this segment.
• The Stool Antigen Test segment shall comprise the 2^nd largest share of the global H. Pylori Non-invasive testing market, accounting for over 40%. Simplicity and accuracy of the test in determining infection is anticipated to drive the segment’s growth.
• By test method, the Laboratory-based Tests segment shall generate high demand. The ability to test a large number of patients and their accurate and precise methodologies are anticipated to be the key drivers. The segment is foreseen to hold more than three-fifth of the market.
• By end-use, diagnostic labs are anticipated to be the most lucrative, capturing almost half of the total market. Key pharmaceutical companies partnering to provide wider reach for testing H. Pylori are anticipated to drive the market. For instance, in 2010, Meridian Bioscience entered into an agreement with DiaSorin S.p.A to develop infectious disease tests for use on its LIAISON automated instrumets.
• North America is anticipated to be the most promising market. This is attributed to changing healthcare reforms. These reforms have directed organizations to abandon serology tests due to its uncertainty in predicting infections and to switch to urea-based and stool antigen testing. The region is anticipated to hold 31.1% of the H. Pylori testing market.
• Asia-Pacific shows modest growth opportunities, owing to increased awareness about H. Pylori infections and government efforts to contain the risk of infections. Moreover, H. Pylori testing among communities with gastric cancer has increased, preventing further risks. The region is anticipated to expand modestly at a CAGR of 4.5%.

Need More Information About Report Methodology? Click Here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4774

“The global helicobacter pylori non-invasive testing market shows modest future growth prospects. The increasing prevalence of h. pylori associated diseases have prompted manufactures to invent non-invasive testing and treatment methods to reduce the incidence of such diseases,” concludes a Fact.MR analyst.

Global Helicobacter Pylori Non-Invasive Testing Market: Competitive Landscape:

The global H. Pylori non-invasive testing market comprises of the following market players: Meridian Bioscience, Inc., DiaSorin S.p.A, Alere, Sekiusi Diagnostics and Biomerica, Inc. Besides these, a host of other players have a significant market presence as well. These are Biohit Oyj, Exalenz Bioscience Ltd., Aalto Bio Reagents Ltd., Certest Biotec S.L. and CorisBioconcept SPRL.

Meridian Bioscience, Inc. markets its tests and assay kits to hospitals, reference laboratories and other diagnostic manufacturers in more than 60 countries. Its H. Pylori testing products include the Premium Platinum HpSA PLUS or Premium H. Pylori. It is an in vitro qualitative procedure to detect the presence of H. Pylori bacteria in the human stool.

Exalenz Biosciences manufactures the H. Pylori IgG ELISA Kit, BreathID HP, BreathID Smart and Breath ID Lab devices. These devices conduct a quick and accurate Urea Breath Test for diagnosing H. Pylori infection and confirming post-treatment eradication. The test is conducted in real-time by continuously sampling breath, eliminating the need for sample collection, labeling, transport and analysis.

Full Access Of This Exclusive Report Is Available At- https://www.factmr.com/checkout/4774/S

COVID-19 Market Insights:

Although there is a dearth of evidence suggesting any links between the COVID-19 and H. Pylori infections, experts have concluded that patients need to be provided treatment on a priority basis. This is because the COVID-19 infection affects the gastrointestinal tract, inducing nausea, vomiting and diarrhea. Since H. Pylori primarily infects the GI tract, it is important for those patients to be provided immediate medical attention if infected with the COVID-19.

As the pandemic is spreading at an exponential rate, key manufacturers are accelerating their efforts to contain its spread. This involves redirecting their resources towards developing COVID-19 testing kits. For instance, Meridian Bioscience has launched the QuickPac II 2019 COVID-19 IgG and IgM qualitative testing kit for the detection of potential antibodies to combat the novel coronavirus strain in the human serum, plasma or blood. Similarly, DiaSorin S.p.A announced the launch of its LIAISON SARS CoV-2 S1/S2 IgG serological test. Such developments are anticipated to shift focus away from H. Pylori testing, leading to a dip in its demand. However, patients requiring urgent care will be provided with the appropriate treatment.

Looking for more information?

The research study on the global helicobacter pyroli (h. pyroli) non-invasive testing market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global helicobacter pyroli (h. pyroli) non-invasive treatment market over 2020-2026. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2026. Market statistics have been presented on the basis of Non-invasive Test Type (Serology Test, Stool Antigen Test and Urea Breath Test), Test Method (Laboratory Based Tests and Point-of-Care Tests) and End User (Hospitals, Diagnostic Laboratories and Clinics) across five major regions.

Helicobacter Pylori infections, or H. Pylori, are the most common types of infections affecting the digestive tract. The infection is prevalent among half of the world’s population, who typically reside in unhygienic and poor sanitary conditions. It is the most common reason for dyspepsia, peptic ulcers and gastric adenocarcinoma.

In view of this, the demand for H. Pylori testing has increased, particularly non-invasive molecular techniques such as real-time PCR and Chemiluminescence Immunoassay (CLIA). The Helicobacter Pylori Non-Invasive Testing market is anticipated to register a moderate CAGR of 3.9% during the forecast period (2020-2026).

Key Takeaways of Global H. Pylori Non-Invasive Testing Market Study:

• By test type, the urea breath test segment is anticipated to hold a major chunk of the market, amounting to over two-fifth. High rate of accuracy in detecting the presence of H. Pylori and usefulness in evaluating post-treatment status are poised to leverage this segment.
• The Stool Antigen Test segment shall comprise the 2^nd largest share of the global H. Pylori Non-invasive testing market, accounting for over 40%. Simplicity and accuracy of the test in determining infection is anticipated to drive the segment’s growth.
• By test method, the Laboratory-based Tests segment shall generate high demand. The ability to test a large number of patients and their accurate and precise methodologies are anticipated to be the key drivers. The segment is foreseen to hold more than three-fifth of the market.
• By end-use, diagnostic labs are anticipated to be the most lucrative, capturing almost half of the total market. Key pharmaceutical companies partnering to provide wider reach for testing H. Pylori are anticipated to drive the market. For instance, in 2010, Meridian Bioscience entered into an agreement with DiaSorin S.p.A to develop infectious disease tests for use on its LIAISON automated instrumets.
• North America is anticipated to be the most promising market. This is attributed to changing healthcare reforms. These reforms have directed organizations to abandon serology tests due to its uncertainty in predicting infections and to switch to urea-based and stool antigen testing. The region is anticipated to hold 31.1% of the H. Pylori testing market.
• Asia-Pacific shows modest growth opportunities, owing to increased awareness about H. Pylori infections and government efforts to contain the risk of infections. Moreover, H. Pylori testing among communities with gastric cancer has increased, preventing further risks. The region is anticipated to expand modestly at a CAGR of 4.5%.

“The global helicobacter pylori non-invasive testing market shows modest future growth prospects. The increasing prevalence of h. pylori associated diseases have prompted manufactures to invent non-invasive testing and treatment methods to reduce the incidence of such diseases,” concludes a Fact.MR analyst.

Global Helicobacter Pylori Non-Invasive Testing Market: Competitive Landscape:

The global H. Pylori non-invasive testing market comprises of the following market players: Meridian Bioscience, Inc., DiaSorin S.p.A, Alere, Sekiusi Diagnostics and Biomerica, Inc. Besides these, a host of other players have a significant market presence as well. These are Biohit Oyj, Exalenz Bioscience Ltd., Aalto Bio Reagents Ltd., Certest Biotec S.L. and CorisBioconcept SPRL.

Meridian Bioscience, Inc. markets its tests and assay kits to hospitals, reference laboratories and other diagnostic manufacturers in more than 60 countries. Its H. Pylori testing products include the Premium Platinum HpSA PLUS or Premium H. Pylori. It is an in vitro qualitative procedure to detect the presence of H. Pylori bacteria in the human stool.

Exalenz Biosciences manufactures the H. Pylori IgG ELISA Kit, BreathID HP, BreathID Smart and Breath ID Lab devices. These devices conduct a quick and accurate Urea Breath Test for diagnosing H. Pylori infection and confirming post-treatment eradication. The test is conducted in real-time by continuously sampling breath, eliminating the need for sample collection, labeling, transport and analysis.

COVID-19 Market Insights:

Although there is a dearth of evidence suggesting any links between the COVID-19 and H. Pylori infections, experts have concluded that patients need to be provided treatment on a priority basis. This is because the COVID-19 infection affects the gastrointestinal tract, inducing nausea, vomiting and diarrhea. Since H. Pylori primarily infects the GI tract, it is important for those patients to be provided immediate medical attention if infected with the COVID-19.

As the pandemic is spreading at an exponential rate, key manufacturers are accelerating their efforts to contain its spread. This involves redirecting their resources towards developing COVID-19 testing kits. For instance, Meridian Bioscience has launched the QuickPac II 2019 COVID-19 IgG and IgM qualitative testing kit for the detection of potential antibodies to combat the novel coronavirus strain in the human serum, plasma or blood. Similarly, DiaSorin S.p.A announced the launch of its LIAISON SARS CoV-2 S1/S2 IgG serological test. Such developments are anticipated to shift focus away from H. Pylori testing, leading to a dip in its demand. However, patients requiring urgent care will be provided with the appropriate treatment.

Looking for more information?

The research study on the global helicobacter pyroli (h. pyroli) non-invasive testing market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global helicobacter pyroli (h. pyroli) non-invasive treatment market over 2020-2026. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2026. Market statistics have been presented on the basis of Non-invasive Test Type (Serology Test, Stool Antigen Test and Urea Breath Test), Test Method (Laboratory Based Tests and Point-of-Care Tests) and End User (Hospitals, Diagnostic Laboratories and Clinics) across five major regions.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com